RAC 0.00% $1.61 race oncology ltd

Ann: Change in substantial holding, page-73

  1. 1,315 Posts.
    lightbulb Created with Sketch. 270
    Conclusions

    • Bisantrene was found to kill ovarian cancer cells confirming the historical Phase II clinical trials

    Man that's huge news, under appreciated by the market, Race Oncology is yet to roar and soar, wait until it does.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.61
Change
0.000(0.00%)
Mkt cap ! $273.4M
Open High Low Value Volume
$1.61 $1.66 $1.60 $207.2K 127.1K

Buyers (Bids)

No. Vol. Price($)
6 25510 $1.60
 

Sellers (Offers)

Price($) Vol. No.
$1.64 12000 1
View Market Depth
Last trade - 15.49pm 29/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.